Japan FFRangio Clinical Outcomes Study

This study aims to collect data on clinical outcomes of real world patients undergoing FFRangio guided treatment for coronary artery disease in Japan and Israel through a retrospective multicentre registry.

Inclusion criteria:• Patients undergoing coronary angiogram for a clinical indication, for whom FFRangio is used to assess the physiologic significance of at least 1 coronary lesion and guide the treatment decisions.Exclusion criteria:Culprit lesion of a STEMI (patients undergoing PCI for non-culprit lesions can be included if the culprit lesion has been successfully treated prior to the non-culprit PCIPresence of significant (moderate+) valvular heart diseaseChronic total occlusion in one of the coronary arteriesIsolated significant left main diseasePrior coronary artery bypass graft surgeryClinical presentation of cardiogenic shock or severe LV dysfunctionCoronary anomalies